Skip to content

Cash ratio at other companies

Insulet logo
InsuletPODD
0.7×-1.8×
Medtronic logo
MedtronicMDT
0.2×0.0×
AdaptHealth logo
AdaptHealthAHCO
0.1×0.0×
Mannkind logo
MannkindMNKD
0.4×0.0×
Abbott logo
AbbottABT
0.4×-0.1×
Omnicell logo
OmnicellOMCL
0.6×-0.1×

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

Based on the most recent quarter.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's cash ratio?
Tandem Diabetes Care (TNDM) reported cash ratio of 0.7× in Q1 2026.
How has Tandem Diabetes Care's cash ratio changed year-over-year?
Tandem Diabetes Care's cash ratio increased by 289.0% year-over-year, from 0.2× to 0.7×.
What is the long-term trend for Tandem Diabetes Care's cash ratio?
Over 5 years (2020 to 2025), Tandem Diabetes Care's cash ratio has grown at a -16.3% compound annual growth rate (CAGR), from 0.9× to 0.4×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.